Tyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx Only, Manufa…
Official notice from a government agency or its published feed.
Reason: Presence of particulate matter:An internal investigation at the firm found the product to contain glass particles.
Class IThe FDA's most serious recall level: a reasonable chance the product could cause serious health problems or death. · Ongoing · Nationwide in the USA
Hazard: Presence of particulate matter:An internal investigation at the firm found the product to contain glass particles.
View the FDA enforcement report ↗ ← All reports